Taco Cabana Expands Beverage Lineup With Cabana Refreshers in Five Vibrant Flavors
Taco Cabana®, a celebrated fast-casual Mexican-inspired dining chain for nearly 50 years, is steering the beverage conversation in a new, fresh and flavorful direction.
Share
'As beverage innovation continues to reshape the quick-service and fast-casual landscape, Taco Cabana is proud to accelerate the momentum with Cabana Refreshers,' said Ulyses Camacho, President and COO of Taco Cabana. 'Our new offerings are bright, flavorful and refreshing, and they showcase our continued commitment to evolving with the category and providing guests with value-driven beverages that elevate the everyday dining experience.'
At $3.29, Cabana Refreshers are made with a zesty lemonade base, then infused with one of five fruity blends that deliver big flavor in every sip. The Pink Blend was created to stand out with its juicy, unexpected flavor combination and eye-catching hue. Whether enjoying popular varieties like Peach or Strawberry, cooling down with the uniquely tangy taste of Mango or mixing it up with the tropical Pink Blend, guests can expect a crisp and satisfying beverage experience in each Cabana Refresher.
All Taco Cabana menu items are available for dine-in, drive-thru, mobile ordering and delivery at all locations throughout Texas. For more information or to find a location near you, visit www.tacocabana.com.
Founded in 1978, Taco Cabana, a subsidiary of YTC Enterprises, LLC, offers Mexican-inspired food including breakfast, lunch and dinner tacos, dozen taco boxes, fajitas, quesadillas, burritos, freshly made flour tortillas and a selection of made-from-scratch salsas and sauces. Restaurants feature open-display cooking, a selection of bottled beer and signature tequila margaritas, patio dining, drive-thru windows, curbside pickup and delivery. Taco Cabana operates nearly 150 company-owned restaurants in Texas and is actively seeking multi-unit franchise partners who are passionate about introducing the successful legacy brand in Arizona, Arkansas, Colorado, Missouri, Oklahoma and Tennessee markets. For more information, visit tacocabana.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Exxon, Chevron turn page on legal fight as profits slip
Lower crude prices dented profits at ExxonMobil and Chevron as the companies signaled Friday they are moving past a legal fight over an acquisition ultimately won by the latter firm. In similar earnings reports, both companies reported second-quarter profit declines despite increased production, with both US giants pumping more from the Permian Basin, a shale-rich region in the states of Texas and New Mexico. But the two companies still garnered enough extra cash to sustain rich shareholder payouts. "The second quarter, once again, proved the value of our strategy and competitive advantages, which continue to deliver for our shareholders no matter the market conditions or geopolitical developments," ExxonMobil CEO Darren Woods said in an earnings statement that touted $9.2 billion in shareholder distributions in the three-month period. ExxonMobil's profits came in at $7.1 billion, down 23.4 percent from the year-ago period. Crude prices were under $65 a barrel, more than $10 less than the level in the 2024 quarter. Revenues fell 12.4 percent to $81.5 billion. The company said it brought online three more of 10 "key" projects due to start in 2025 that will lead to growth. The projects included upgrades to existing facilities in Singapore and Britain to produce more high-value products from low-quality petroleum feedstocks, as well as a renewable diesel venture in Canada. Chevron, meanwhile, reported profits of $2.5 billion, down 43.4 percent from the year-ago level. Revenues dropped 12.4 percent to $44.8 billion. Chevron pumped 3.4 million barrels of oil equivalent per day during the quarter, well below the 4.4 million of oil equivalent produced by ExxonMobil. - Closing the gap - But Chevron CEO Mike Wirth said the company expects to end 2025 close to four million barrels per day following the completion of its $53 billion acquisition of US company Hess, which was delayed for more than a year following a legal spat with ExxonMobil. ExxonMobil had contested Chevron's right to take over Hess' interest in an offshore field in Guyana in which ExxonMobil holds the largest stake. But on July 18, Chevron announced that it completed the transaction following a "favorable" outcome in the arbitration dispute with ExxonMobil. Wirth said the legal dispute had given it more time to plan out integration, enabling it to speed up $1 billion in annual efficiency gains six months faster than the original plan. The extra time also means that Chevron has already repurchased more than 50 percent of company shares it had planned to issue for the Hess transaction, officials said on a conference call. Chevron spent $5.5 billion in shareholder distributions in the second quarter. In an interview with CNBC, Woods said he was surprised at the outcome of the Hess arbitration, but had called Wirth and John Hess of Hess to congratulate them. "We're moving on from that," Woods told the network. "It's time to move forward and continue on the business." Such frictions typify comportment in the oil industry, where huge capital outlays require rivals to work together on individual projects even when they compete. "You have to learn to walk and balance between, on the one hand, being partners and working closely together, and on the other hand, fiercely competing," Woods said. "I have no doubt we'll continue to have a constructive partnership." Shares of ExxonMobil fell 1.7 percent in afternoon trading, while Chevron slipped 0.5 percent. jmb/wd
Business Upturn
11 hours ago
- Business Upturn
HIMS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Marion Passmore Encourage Investors Who Suffered Losses In Hims To Contact Them To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 23, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ('Hims & Hers' or the 'Company') (NYSE:HIMS) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Hims securities between April 29, 2025 and June 23, 2025, both dates inclusive (the 'Class Period'). Investors have until August 25, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to participate in the action. The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants failed to disclose to investors: (1) that Hims was engaged in the 'deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk;' (2) that, as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Additionally, the Complaint alleges that Defendants made false and/or misleading statements, as well as failed to disclose material facts, including that: (1) the communication between Hims and the pharmaceutical company Novo Nordisk A/S ('Novo') would facilitate a long-term collaboration that would ensure continued access to the weight-loss drug Wegovy for Hims subscribers; (2) Novo approved of Hims' offerings of compounded semaglutide products under the 'personalization' exception; (3) branded Wegovy would be offered alongside compounded semaglutide options on the Hims platform, thereby expanding user choice; and (4) Defendants made positive statements abou the Novo partnership and Hims users' ongoing access to Wegovy alongside compounded semaglutide products. If you purchased or otherwise acquired Hims & Hers shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit . Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, Walker, Passmore, Esq.(212) 355-4648 [email protected]
Yahoo
13 hours ago
- Yahoo
UnitedHealth Group Announces Changes to Leadership Team
July 31, 2025--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today announced Wayne S. DeVeydt has been appointed its chief financial officer, effective September 2, 2025. John F. Rex, who joined the company in 2012 and has been CFO since 2016, will become strategic advisor to the CEO on the same date. "Wayne DeVeydt combines deep financial acumen and operating experience with the mission-oriented and compassionate approach to health care that is a perfect fit for UnitedHealth Group," said Stephen J. Hemsley, company chairman and chief executive officer. "John Rex has been an exceptional leader, having helped guide our company through substantial change with both strategic vision and strong commitment to our mission," said Hemsley. "I look forward to his continued insights as UnitedHealth Group moves forward." DeVeydt, 55, most recently has been a managing director and operating partner at Bain Capital, working with client leaders on operational improvement and growth acceleration. From 2018-2020, he was chairman and CEO of Surgery Partners, Inc. in Nashville, expanding the operational scale and financial performance of the surgical services firm. He joined Anthem, Inc. (now Elevance) in 2005 and served as its chief financial officer from 2007 to 2016. Prior to joining Anthem, DeVeydt served as a partner with PricewaterhouseCoopers LLP, with a focus on the health care sector. "There is no organization besides UnitedHealth Group that presents the kinds of opportunities to make a difference in health care, from individual patient care to broad system efficiency, so I am eagerly looking forward to joining the team," said DeVeydt. "I've been fortunate to know John Rex for over two decades and am honored to follow a leader of his caliber." Rex, 63, joined UnitedHealth Group as chief financial officer of the company's then newly established Optum business and previously had spent his career focused in health care across multiple roles and sectors. "This pivotal moment for UnitedHealth Group is the right time for a new yet greatly experienced executive like Wayne DeVeydt, and I look forward to supporting him and the entire leadership team while continuing to advise on a range of matters," said Rex. About UnitedHealth Group UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at and follow UnitedHealth Group on LinkedIn. View source version on Contacts Media: uhgmedia@ UnitedHealth Group Media Sign in to access your portfolio
